A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion

NCT06115512 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease

Interventions

DRUG: AGA111
DRUG: Placebo

Sponsor

Angitia Biopharmaceuticals